# FDA recall D-0299-2020

> **Taro Pharmaceuticals U.S.A., Inc.** · Class II · drug recall initiated 2019-09-27.

## Product

Ibuprofen Oral Suspension USP, 100 mg/5 mL, One Pint, (473 mL), Rx only, Manufactured by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Distributed by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1385-9

## Reason for recall

Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

## Distribution

U.S.A. Nationwide

## Key facts

- **Recall number:** D-0299-2020
- **Recalling firm:** Taro Pharmaceuticals U.S.A., Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-09-27
- **Report date:** 2019-11-06
- **Termination date:** 2023-08-31

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Hawthorne, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0299-2020

## Citation

> AI Analytics. FDA recall D-0299-2020. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0299-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*